Results 21 to 30 of about 2,743,257 (209)

Hepatitis C Core-Antigen Testing from Dried Blood Spots [PDF]

open access: yesViruses, 2019
In order to expand hepatitis C virus (HCV) screening, a change in the diagnostic paradigm is warranted to improve accessibility and decrease costs, such as utilizing dried blood spot (DBS) collection. In our study, blood from 68 patients with chronic HCV
Mia J. Biondi   +16 more
doaj   +2 more sources

Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients' PBMCs. [PDF]

open access: yesJ Clin Exp Hepatol, 2023
Abstract Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver. This study aimed to assess serum hTERT level and its relation to the progression of liver disease. Also, it aimed to assess the effect of HCV core protein on memory T-cells in HCV patients with or without HCC, and the correlation between memory ...
Ibrahim IH   +4 more
europepmc   +3 more sources

Identification of novel neutralizing determinants for protection against HCV

open access: yesHepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua   +12 more
wiley   +1 more source

Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2020
Background and study aim: PCR is currently the non-debatable proof for diagnosis of HCV infection as well as conclusion of treatment outcomes. HCV core antigen (HCVcAg) testing is a neglected, less expensive and less time-consuming test that’s presumed ...
Mohammed Nouh   +3 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Development of ELISA method for primary detection of HCV using core antigen [PDF]

open access: yes, 2011
Studies show that Hepatitis C Virus (HCV) antigens appear before antibody while the early days of infection. Therefore detecting antigens could lead us to diagnosing the infection on time.
Hashemi, Masoomeh   +6 more
core   +1 more source

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs. [PDF]

open access: yesPeerJ, 2017
The core antigen of the hepatitis C virus (HCV Ag) presents an alternative marker to HCV RNA when screening patients for HCV viremia. This study sought to evaluate the utility of HCV Ag as a marker to assess active HCV infection in individuals residing ...
Wasitthankasem R   +7 more
europepmc   +4 more sources

Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan

open access: yesJournal of the Formosan Medical Association, 2020
Background and purpose: Hepatitis C virus (HCV) core antigen is highly sensitive and specific in viremic HCV diagnosis. This study evaluated the cost-effectiveness of HCV core antigen (HCVcAg) in community-based screening for active HCV infection ...
Jing-Houng Wang   +5 more
doaj   +1 more source

Seroprevalence of hepatitis C virus in Jinan, China, 2008–2020

open access: yesEuropean Journal of Medical Research, 2023
Background The updated estimates of hepatitis C virus (HCV) seroprevalence are critical for developing strategies to manage or eliminate HCV infection.
Mingjie Xu   +5 more
doaj   +1 more source

Evaluation of ARCHITECT HCV Core Antigen Assay

open access: yesAnnals of Laboratory Medicine, 2010
Hepatitis C virus (HCV) core antigen (Ag) levels are known to be well correlating with HCV RNA levels, and may be used as an alternative marker of HCV replication for monitoring the response to HCV treatment. However, the low sensitivity of HCV core Ag assay has been an obstacle for clinical use. In this study, recently developed ARCHITECT HCV Ag assay
Dual, Song   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy